Home›Stock Screener›Gland Pharma›P/E Ratio

Gland Pharma P/E Ratio

Current P/E Ratio
42.71
High Valuation
Very High - High growth expectations or significantly overvalued

Gland Pharma (GLAND) P/E ratio is 42.71 (High), EPS (TTM) ₹62.35, current price ₹2961.90 on NSE vs historical average P/E of 41.09 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. Also explore GLAND stock price history to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 42.71
Current Price ₹2961.90
EPS (TTM) ₹62.35
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 41.09
Historical Range 30.45 - 64.12
Percentile 66.7%

Sector Context

Sector Average 56.81
Sector Median 31.66
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹63.96
Mar 2026 ₹22.26
Jun 2026 ₹19.23

GLAND P/E Ratio — Valuation Signal & Historical Context

Gland Pharma P/E 42.71 vs historical average 41.09, range 30.45–64.12 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Gland Pharma share price screener.

  • Stock appears overvalued with PE of 42.71, suggesting caution for new investments
  • Trading at discount to sector average PE of 56.81

Gland Pharma P/E Ratio Historical Trend

GLAND annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 42.71 vs historical average 41.09.

GLAND Historical P/E Ratio — EPS, Year-End Price & Valuation

Gland Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 35.2 51.42 ₹1810.10 NSE High
2024 44.59 42.76 ₹1906.55 NSE High
2023 39.4 40.0 ₹1575.90 NSE High
2022 64.12 60.06 ₹3851.30 NSE High
2021 32.76 72.33 ₹2369.70 NSE High
2020 30.45 59.76 ₹1819.55 NSE High

GLAND vs Healthcare Peers — P/E Ratio Comparison

Gland Pharma P/E 42.71 vs Healthcare average 56.81, median 31.66 — range 1.99–747.21.

Sector Average
56.81
Sector Median
31.66
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 1.99 ₹66 Low
Murae Organisor MURAE 2.86 ₹41 Low
Colinz Laboratories COLINZ 3.27 ₹9 Low
Phaarmasia PHRMASI 3.41 ₹59 Low
Sun Pharma Advanced Rese… SPARC 4.03 ₹6,361 Low
Dipna Pharmachem DPL 4.65 ₹12 Low
JFL Life Sciences JFLLIFE 4.95 ₹67 Low
Shelter Pharma SHELTER 5.71 ₹56 Low
GKB Ophthalmics GKB 5.9 ₹33 Low
Kabra Drugs KABRADG 6.29 ₹49 Low